Position in MNKD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,390,000
-$19,809,997 QoQ
Shares Held
2,200,000
-50.5% QoQ
Ownership
0.712%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MNKD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Avoro Capital Advisors LLC holds $8,549,473,651 across 28 Biotechnology names. MNKD ranks #28 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
5,062,500 | $1,157,945,625 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,818,181 | $951,763,208 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
2,888,888 | $746,257,548 | |
| 4 | ARGX |
Argenx SE
|
1,000,000 | $730,250,000 | |
| 5 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
10,699,999 | $670,889,937 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
7,474,747 | $622,571,677 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
12,222,222 | $491,699,991 | |
| 8 | CNTA |
Centessa Pharmaceuticals plc
|
11,430,455 | $454,017,672 |
All Filings in MNKD
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,390,000 | 2,200,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $25,199,997 | 4,444,444 | Shares | Sole | 2026-03-16 | |
| 2025-09-30 | $23,997,869 | 4,468,877 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $21,879,000 | 5,850,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $44,012,500 | 8,750,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $56,262,500 | 8,750,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $55,037,500 | 8,750,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $45,724,715 | 8,759,524 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $40,770,000 | 9,000,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $32,760,000 | 9,000,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $37,170,000 | 9,000,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $37,037,000 | 9,100,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $37,310,000 | 9,100,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $47,957,000 | 9,100,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $28,119,000 | 9,100,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $34,671,000 | 9,100,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $32,384,000 | 8,800,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $38,456,000 | 8,800,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $38,280,000 | 8,800,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $47,033,500 | 8,630,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $29,400,000 | 7,500,000 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $10,955,000 | 3,500,000 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||